Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Signoretti

Showing results (61-70 of 257) with videos related to

Pageof 26
Sort By:
Nature|September 13, 2002
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformationNabeel Bardeesy, Manisha Sinha, Aram F Hezel, et al.
Clinical Genitourinary Cancer|March 13, 2025
CDK4/6 Inhibition With Abemaciclib in Patients With Previously Treated Advanced Renal Cell CarcinomaBradley A McGregor, Wanling Xie, Stephanie A Berg, et al.
Clinical Genitourinary Cancer|October 25, 2007
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinomaDaniel Cho, Sabina Signoretti, Sandra Dabora, et al.
AJR. American Journal of Roentgenology|June 20, 2008
Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapyAdeel Sabir, Rachel Schor-Bardach, Carol J Wilcox, et al.
Molecular Cancer Therapeutics|August 12, 2010
Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signalingRupal S Bhatt, Xiaoen Wang, Liang Zhang, et al.
Nature|January 28, 2016
Corrigendum: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Nature|July 3, 2008
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Nature|April 24, 2025
Editorial Expression of Concern: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Cancer Discovery|December 22, 2012
Opposing effects of androgen deprivation and targeted therapy on prostate cancer preventionShidong Jia, Xueliang Gao, Sang Hyun Lee, et al.
Journal of Translational Medicine|December 23, 2011
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinomaXiaoen Wang, Liang Zhang, S Nahum Goldberg, et al.
Pageof 26

Showing results (61-70 of 257) with videos related to

Sort By:
Pageof 26
Nature|September 13, 2002
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformationNabeel Bardeesy, Manisha Sinha, Aram F Hezel, et al.
Clinical Genitourinary Cancer|March 13, 2025
CDK4/6 Inhibition With Abemaciclib in Patients With Previously Treated Advanced Renal Cell CarcinomaBradley A McGregor, Wanling Xie, Stephanie A Berg, et al.
Clinical Genitourinary Cancer|October 25, 2007
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinomaDaniel Cho, Sabina Signoretti, Sandra Dabora, et al.
AJR. American Journal of Roentgenology|June 20, 2008
Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapyAdeel Sabir, Rachel Schor-Bardach, Carol J Wilcox, et al.
Molecular Cancer Therapeutics|August 12, 2010
Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signalingRupal S Bhatt, Xiaoen Wang, Liang Zhang, et al.
Nature|January 28, 2016
Corrigendum: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Nature|July 3, 2008
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Nature|April 24, 2025
Editorial Expression of Concern: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Cancer Discovery|December 22, 2012
Opposing effects of androgen deprivation and targeted therapy on prostate cancer preventionShidong Jia, Xueliang Gao, Sang Hyun Lee, et al.
Journal of Translational Medicine|December 23, 2011
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinomaXiaoen Wang, Liang Zhang, S Nahum Goldberg, et al.
Pageof 26